Vanda Pharmaceuticals (VNDA) Shares Outstanding (2009 - 2026)

Vanda Pharmaceuticals' Shares Outstanding history runs 18 years deep, the most recent figure standing at $60.1 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 2.04% year-over-year to $60.1 million; the TTM figure through Mar 2026 stood at $60.1 million (up 2.04% YoY), while the FY2025 annual figure was $59.1 million, up 1.36% from the prior year.
• Shares Outstanding came in at $60.1 million for Q1 2026 at Vanda Pharmaceuticals, up from $59.1 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $60.1 million in Q1 2026 to a low of $56.5 million in Q1 2022.
• A 5-year average of $58.0 million and a median of $58.2 million in 2024 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding increased 1.27% in 2025 and advanced 2.04% in 2026, its largest moves.
• Vanda Pharmaceuticals' Shares Outstanding stood at $56.8 million in 2022, then rose by 1.32% to $57.5 million in 2023, then grew by 1.35% to $58.3 million in 2024, then gained by 1.36% to $59.1 million in 2025, then gained by 1.75% to $60.1 million in 2026.
• According to Business Quant data, Shares Outstanding over the past three periods registered $60.1 million, $59.1 million, and $59.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison